This case report demonstrates improved quality of life in a patient with metastatic prostate cancer, suggesting potential benefits of Korean medicine.
Objective: This study investigated the treatment response to Korean medicine in a patient with metastatic prostate cancer with pleural effusion and hematuria.Case presentation: A 69-year-old male diagnosed with metastatic prostate cancer complained of dyspnea due to pleural effusion, general weakness, and hematuria. He received Korean medicine, including modified Jeoryeong-tang and Shipjeondaebo-tang, acupuncture, moxibustion, and cupping, combined with Western medicine and physical therapy for 92 days. General physical status improved, with significant decreases in ECOG performance status and PHQ-4 scores.Conclusion: Complex Korean medicine treatment may improve quality of life in patients with metastatic prostate cancer. However, further studies without concurrent Western medicine are required.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: